Effects of Recombinant Human Interleukin-1α and 1,25-(OH)2D3 on the Gene Expression of RANKL and OPG in HPDLFs
Jianmin Chen
Abstract
Jianmin Chen
Abstract
Objective: To evaluate the effects of rhIL-1α and 1,25-(OH)2D3 on the expression of RANKL and OPG in HPDLFs and to discuss the change of ratio of RANKL/OPG.Methods: HPDLFs were treated with 10ng/ml rhIL-1α,1×10-8mol/L 1,25-(OH)2D3 or 10ng/ml rhIL-1α plus 1×10-8mol/L 1,25-(OH)2D3 for 48 hours.The expression of RANKL and OPG were measured by FQ-RT-PCR.Results: RhIL-1α and 1,25(OH)2D3 influenced the expression of RANKL and OPG in HPDLFs.The expression of RANKL and OPG were increased with rhIL-1α(P0.05).Moreover,1,25(OH)2D3 up regulated the expression of RANKL and decreased the expression of OPG,so the ratio of RANKL/OPG was increased too(P0.05).There was cumulative effect on regulating the expression of RANKLwith the synergistic use of rhIL-1αand 1,25(OH)2D3,but there was no cumulative effect on the ratio of RANKL/OPG.Conclusion: RhIL-1α and 1,25-(OH)2D3 act through RANKL-OPG pathway to regulate the alveolar bone remolding.There was additive effect on the expression of RANKL with combination use of rhIL-1α and 1,25-(OH)2D3,but there was no additive effect or synergistic effect on the ratio of RANKL/OPG.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To evaluate the effects of rhIL-1α and 1,25-(OH)2D3 on the expression of RANKL and OPG in HPDLFs and to discuss the change of ratio of RANKL/OPG.Methods: HPDLFs were treated with 10ng/ml rhIL-1α,1×10-8mol/L 1,25-(OH)2D3 or 10ng/ml rhIL-1α plus 1×10-8mol/L 1,25-(OH)2D3 for 48 hours.The expression of RANKL and OPG were measured by FQ-RT-PCR.Results: RhIL-1α and 1,25(OH)2D3 influenced the expression of RANKL and OPG in HPDLFs.The expression of RANKL and OPG were increased with rhIL-1α(P0.05).Moreover,1,25(OH)2D3 up regulated the expression of RANKL and decreased the expression of OPG,so the ratio of RANKL/OPG was increased too(P0.05).There was cumulative effect on regulating the expression of RANKLwith the synergistic use of rhIL-1αand 1,25(OH)2D3,but there was no cumulative effect on the ratio of RANKL/OPG.Conclusion: RhIL-1α and 1,25-(OH)2D3 act through RANKL-OPG pathway to regulate the alveolar bone remolding.There was additive effect on the expression of RANKL with combination use of rhIL-1α and 1,25-(OH)2D3,but there was no additive effect or synergistic effect on the ratio of RANKL/OPG.
Key concepts: RANKL, Chemistry, Internal medicine, Endocrinology, Osteoprotegerin, Medicine, Receptor, Activator (genetics)